Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
18168 | 563 | 41.5 | 91% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
268 | 3 | NEUROTROPHINS//BRAIN DERIVED NEUROTROPHIC FACTOR//BDNF | 44049 |
879 | 2 | NEUROTROPHINS//BRAIN DERIVED NEUROTROPHIC FACTOR//BDNF | 11456 |
18168 | 1 | TRKA//TRKB//P75NTR | 563 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | TRKA | authKW | 325402 | 10% | 10% | 59 |
2 | TRKB | authKW | 284309 | 11% | 8% | 62 |
3 | P75NTR | authKW | 207528 | 7% | 10% | 40 |
4 | AZ64 | authKW | 162707 | 1% | 100% | 3 |
5 | TROPOMYOSIN RECEPTOR KINASES | authKW | 162707 | 1% | 100% | 3 |
6 | TRK INHIBITOR | authKW | 108471 | 0% | 100% | 2 |
7 | TRK INHIBITORS | authKW | 108471 | 0% | 100% | 2 |
8 | TRKA INHIBITOR | authKW | 108471 | 0% | 100% | 2 |
9 | TRKA KINASE | authKW | 108471 | 0% | 100% | 2 |
10 | TRKB NTRK2 | authKW | 108471 | 0% | 100% | 2 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Oncology | 5022 | 49% | 0% | 275 |
2 | Cell Biology | 815 | 21% | 0% | 117 |
3 | Biochemistry & Molecular Biology | 272 | 22% | 0% | 123 |
4 | Pathology | 219 | 6% | 0% | 35 |
5 | Chemistry, Medicinal | 105 | 5% | 0% | 27 |
6 | Genetics & Heredity | 75 | 6% | 0% | 35 |
7 | Medicine, Research & Experimental | 38 | 4% | 0% | 24 |
8 | Endocrinology & Metabolism | 33 | 4% | 0% | 24 |
9 | CYTOLOGY & HISTOLOGY | 25 | 0% | 0% | 2 |
10 | Hematology | 20 | 3% | 0% | 15 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | U GROWTH TOR SIGNALING BREAST CANC CELLS FUNCT | 108471 | 0% | 100% | 2 |
2 | VINCENT T LOMBARDI COMPREHENS CANC | 96843 | 1% | 36% | 5 |
3 | MOL DIS CELL REGULAT | 78883 | 1% | 36% | 4 |
4 | CELL MOL BIOL SECT | 78106 | 2% | 13% | 11 |
5 | CANC NEUROBIOL | 69728 | 1% | 43% | 3 |
6 | CLIN HOSP CPE HCPA | 69728 | 1% | 43% | 3 |
7 | ABRAHAMSON 916 | 54236 | 0% | 100% | 1 |
8 | AFFILIATED PLA CLIN | 54236 | 0% | 100% | 1 |
9 | AFLAC CANC BLOOD SERV | 54236 | 0% | 100% | 1 |
10 | ALLIED HLTH PROFESS MIDWIFEIY | 54236 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | ONCOGENE | 1846 | 4% | 0% | 25 |
2 | GROWTH FACTORS | 1698 | 1% | 1% | 5 |
3 | CLINICAL CANCER RESEARCH | 1159 | 3% | 0% | 18 |
4 | CELL GROWTH & DIFFERENTIATION | 954 | 1% | 0% | 5 |
5 | ONCOLOGY REPORTS | 905 | 2% | 0% | 13 |
6 | CANCER RESEARCH | 641 | 4% | 0% | 22 |
7 | PROSTATE | 573 | 1% | 0% | 7 |
8 | CANCER MEDICINE | 543 | 1% | 0% | 3 |
9 | BIOSCIENCE TRENDS | 466 | 0% | 0% | 2 |
10 | CANCER LETTERS | 432 | 2% | 0% | 10 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | TRKA | 325402 | 10% | 10% | 59 | Search TRKA | Search TRKA |
2 | TRKB | 284309 | 11% | 8% | 62 | Search TRKB | Search TRKB |
3 | P75NTR | 207528 | 7% | 10% | 40 | Search P75NTR | Search P75NTR |
4 | AZ64 | 162707 | 1% | 100% | 3 | Search AZ64 | Search AZ64 |
5 | TROPOMYOSIN RECEPTOR KINASES | 162707 | 1% | 100% | 3 | Search TROPOMYOSIN+RECEPTOR+KINASES | Search TROPOMYOSIN+RECEPTOR+KINASES |
6 | TRK INHIBITOR | 108471 | 0% | 100% | 2 | Search TRK+INHIBITOR | Search TRK+INHIBITOR |
7 | TRK INHIBITORS | 108471 | 0% | 100% | 2 | Search TRK+INHIBITORS | Search TRK+INHIBITORS |
8 | TRKA INHIBITOR | 108471 | 0% | 100% | 2 | Search TRKA+INHIBITOR | Search TRKA+INHIBITOR |
9 | TRKA KINASE | 108471 | 0% | 100% | 2 | Search TRKA+KINASE | Search TRKA+KINASE |
10 | TRKB NTRK2 | 108471 | 0% | 100% | 2 | Search TRKB+NTRK2 | Search TRKB+NTRK2 |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | AKIL, H , PERRAUD, A , JAUBERTEAU, MO , MATHONNET, M , (2016) TROPOMYOSIN-RELATED KINASE B/BRAIN DERIVED-NEUROTROPHIC FACTOR SIGNALING PATHWAY AS A POTENTIAL THERAPEUTIC TARGET FOR COLORECTAL CANCER.WORLD JOURNAL OF GASTROENTEROLOGY. VOL. 22. ISSUE 2. P. 490 -500 | 60 | 51% | 1 |
2 | CROUCHER, JL , IYER, R , LI, NX , MOLTENI, V , LOREN, J , GORDON, WP , TUNTLAND, T , LIU, B , BRODEUR, GM , (2015) TRKB INHIBITION BY GNF-4256 SLOWS GROWTH AND ENHANCES CHEMOTHERAPEUTIC EFFICACY IN NEUROBLASTOMA XENOGRAFTS.CANCER CHEMOTHERAPY AND PHARMACOLOGY. VOL. 75. ISSUE 1. P. 131 -141 | 46 | 67% | 3 |
3 | IYER, R , WEHRMANN, L , GOLDEN, RL , NARAPARAJU, K , CROUCHER, JL , MACFARLAND, SP , GUAN, P , KOLLA, V , WEI, G , CAM, N , ET AL (2016) ENTRECTINIB IS A POTENT INHIBITOR OF TRK-DRIVEN NEUROBLASTOMAS IN A XENOGRAFT MOUSE MODEL.CANCER LETTERS. VOL. 372. ISSUE 2. P. 179 -186 | 45 | 55% | 1 |
4 | DEMIR, IE , TIEFTRUNK, E , SCHORN, S , FRIESS, H , CEYHAN, GO , (2016) NERVE GROWTH FACTOR & TRKA AS NOVEL THERAPEUTIC TARGETS IN CANCER.BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER. VOL. 1866. ISSUE 1. P. 37 -50 | 60 | 41% | 1 |
5 | CHOPIN, V , LAGADEC, C , TOILLON, RA , LE BOURHIS, X , (2016) NEUROTROPHIN SIGNALING IN CANCER STEM CELLS.CELLULAR AND MOLECULAR LIFE SCIENCES. VOL. 73. ISSUE 9. P. 1859 -1870 | 52 | 43% | 2 |
6 | VANHECKE, E , ADRIAENSSENS, E , VERBEKE, S , MEIGNAN, S , GERMAIN, E , BERTEAUX, N , NURCOMBE, V , LE BOURHIS, X , HONDERMARCK, H , (2011) BRAIN-DERIVED NEUROTROPHIC FACTOR AND NEUROTROPHIN-4/5 ARE EXPRESSED IN BREAST CANCER AND CAN BE TARGETED TO INHIBIT TUMOR CELL SURVIVAL.CLINICAL CANCER RESEARCH. VOL. 17. ISSUE 7. P. 1741-1752 | 30 | 70% | 35 |
7 | THIELE, CJ , LI, ZJ , MCKEE, AE , (2009) ON TRK-THE TRKB SIGNAL TRANSDUCTION PATHWAY IS AN INCREASINGLY IMPORTANT TARGET IN CANCER BIOLOGY.CLINICAL CANCER RESEARCH. VOL. 15. ISSUE 19. P. 5962-5967 | 38 | 51% | 96 |
8 | LI, L , ZHU, L , (2017) EXPRESSION AND CLINICAL SIGNIFICANCE OF TRKB IN SINONASAL SQUAMOUS CELL CARCINOMA: A PILOT STUDY.INTERNATIONAL JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY. VOL. 46. ISSUE 2. P. 144 -150 | 23 | 79% | 0 |
9 | HUA, ZY , GU, X , DONG, YD , TAN, F , LIU, ZH , THIELE, CJ , LI, ZJ , (2016) PI3K AND MAPK PATHWAYS MEDIATE THE BDNF/TRKB-INCREASED METASTASIS IN NEUROBLASTOMA.TUMOR BIOLOGY. VOL. 37. ISSUE 12. P. 16227 -16236 | 28 | 65% | 0 |
10 | IYER, R , VARELA, CR , MINTURN, JE , HO, R , SIMPSON, AM , LIGHT, JE , EVANS, AE , ZHAO, HQ , THRESS, K , BROWN, JL , ET AL (2012) AZ64 INHIBITS TRKB AND ENHANCES THE EFFICACY OF CHEMOTHERAPY AND LOCAL RADIATION IN NEUROBLASTOMA XENOGRAFTS.CANCER CHEMOTHERAPY AND PHARMACOLOGY. VOL. 70. ISSUE 3. P. 477-486 | 35 | 54% | 6 |
Classes with closest relation at Level 1 |